Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. | Canada Hyperbarics Skip to main content
Retrospective Study European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2011

Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases.

Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M — European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively examined patient files from 2004 to 2010 to compare the efficacy of oral steroid, intratympanic steroid, hyperbaric oxygen, and combination therapies for idiopathic sudden sensorineural hearing loss.

What They Found

Among 217 patients, the oral steroid plus hyperbaric oxygen group showed the highest response rate at 86.88% (53/61) and complete recovery rate at 42.6% (26/61). This combination also achieved the highest mean hearing gain, significantly outperforming oral steroid (63.79% response), intratympanic steroid (46.51% response), and hyperbaric oxygen alone (43.85% response).

What This Means for Canadian Patients

Canadian patients with idiopathic sudden sensorineural hearing loss may experience better outcomes with a combined treatment of oral steroids and hyperbaric oxygen. This approach appears more effective for both overall response and complete hearing recovery than individual therapies.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in another country.

Study Limitations

A limitation of this study is its retrospective design, which may introduce biases and limit the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 21431435
Year Published 2011
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Administration, Oral; Administration, Topical; Audiometry; Follow-Up Studies; Glucocorticoids; Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Recovery of Function; Retrospective Studies; Treatment Outcome; Tympanic Membrane

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.